Skin loses its elasticity when fat disappears quickly, leaving loose tissue that diet and exercise struggle to correct
Wu, Y., Zeng, F., Zhao, Y
Read the full blog: #GLP1 #IQVIAInsights Luke Greenwalt Anika LaFazia To view or add a comment, sign in More Relevant Posts Side-by-side from 2006 2024, one trend jumps out: Less of the healthcare dollar going to physician visits More going to prescription drugs + therapies The categories arent apples-to-apples, but the direction is clear: - -
Tirzepatide, the first approved dual GIP/GLP-1 receptor agonist, is a 39-amino acid peptide with an approximately 120-hour half-life supporting once-weekly dosing
Meanwhile, 5-Amino-1MQ emerged from studies at Washington University showing that nicotinamide N-methyltransferase (NNMT) inhibition restores NAD+ pools depleted during metabolic dysfunction, effectively reversing the mitochondrial slowdown that makes weight loss progressively harder
A systematic review found that combining GLP-1 receptor agonist therapy with structured exercise programs led to greater weight loss compared to medication alone